Suppr超能文献

统一A组链球菌疾病的监测方法

Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases.

作者信息

Moore Hannah C, Miller Kate M, Carapetis Jonathan R, Van Beneden Chris A

机构信息

Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.

Perth Children's Hospital, Perth, Western Australia, Australia.

出版信息

Open Forum Infect Dis. 2022 Sep 15;9(Suppl 1):S1-S4. doi: 10.1093/ofid/ofac210. eCollection 2022 Sep.

Abstract

Group A (Strep A) is responsible for a significant global health and economic burden. The recent prioritization of Strep A vaccine development by the World Health Organization has prompted global research activities and collaborations. To progress this prioritization, establishment of robust surveillance for Strep A to generate updated regional disease burden estimates and to establish platforms for future impact evaluation is essential. Through the activities of the Strep A Vaccine Global Consortium (SAVAC), we have refined and harmonized surveillance protocols for 7 Strep A disease endpoints with a view that these will form part of surveillance standards for ongoing research and public health activities.

摘要

A组(A群链球菌)给全球带来了重大的健康和经济负担。世界卫生组织最近将A群链球菌疫苗研发列为优先事项,这推动了全球范围内的研究活动与合作。为推动这一优先事项的进展,建立强大的A群链球菌监测体系以生成最新的区域疾病负担估计数,并建立未来影响评估平台至关重要。通过A群链球菌疫苗全球联盟(SAVAC)的活动,我们完善并统一了针对7个A群链球菌疾病终点的监测方案,以期这些方案将成为正在进行的研究和公共卫生活动监测标准的一部分。

相似文献

1
Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases.
Open Forum Infect Dis. 2022 Sep 15;9(Suppl 1):S1-S4. doi: 10.1093/ofid/ofac210. eCollection 2022 Sep.
2
The Streptococcus pyogenes vaccine landscape.
NPJ Vaccines. 2023 Feb 14;8(1):16. doi: 10.1038/s41541-023-00609-x.
3
The Australian burden of invasive group A streptococcal disease: a narrative review.
Intern Med J. 2021 Jun;51(6):835-844. doi: 10.1111/imj.14885.
4
Standardization of Epidemiological Surveillance of Invasive Group A Streptococcal Infections.
Open Forum Infect Dis. 2022 Sep 15;9(Suppl 1):S31-S40. doi: 10.1093/ofid/ofac281. eCollection 2022 Sep.
5
WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12-13 December 2016.
Vaccine. 2018 Jun 7;36(24):3397-3405. doi: 10.1016/j.vaccine.2018.02.068. Epub 2018 Feb 26.

引用本文的文献

1
Capturing the complete clinical spectrum and incidence of severe acute Group A (GAS) disease: a population-based study in Auckland, New Zealand.
Lancet Reg Health West Pac. 2025 Jun 12;59:101600. doi: 10.1016/j.lanwpc.2025.101600. eCollection 2025 Jun.
2
Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.
NPJ Vaccines. 2023 Jul 14;8(1):102. doi: 10.1038/s41541-023-00695-x.
3
Correlates of immunity to Group A Streptococcus: a pathway to vaccine development.
NPJ Vaccines. 2023 Jan 17;8(1):1. doi: 10.1038/s41541-022-00593-8.

本文引用的文献

1
The global burden of sore throat and group A pharyngitis: A systematic review and meta-analysis.
EClinicalMedicine. 2022 May 20;48:101458. doi: 10.1016/j.eclinm.2022.101458. eCollection 2022 Jun.
3
Global burden of rheumatic heart disease and its association with socioeconomic development status, 1990-2019.
Eur J Prev Cardiol. 2022 Aug 5;29(10):1425-1434. doi: 10.1093/eurjpc/zwac044.
5
WHO Resolution on rheumatic heart disease.
Eur Heart J. 2018 Dec 21;39(48):4233. doi: 10.1093/eurheartj/ehy764.
6
An economic case for a vaccine to prevent group A streptococcus skin infections.
Vaccine. 2018 Nov 12;36(46):6968-6978. doi: 10.1016/j.vaccine.2018.10.001. Epub 2018 Oct 16.
8
The global burden of group A streptococcal diseases.
Lancet Infect Dis. 2005 Nov;5(11):685-94. doi: 10.1016/S1473-3099(05)70267-X.
9
Surveillance projects for selected diseases.
Int J Epidemiol. 1976 Mar;5(1):29-37. doi: 10.1093/ije/5.1.29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验